1. Article | 2024.04.30

    Paul-Louis Simond, world traveler working on multiple diseases

    A French naval medical officer, Paul-Louis Simond traveled the world and studied many diseases. After heading up a leprosarium in French Guiana from the age of 24, he spent several years in Indochina where he battled smallpox, and then in China.

  2. Document de presse | 2024.05.28

    AFROSCREEN: a key network for genomic surveillance in Sub-Saharan Africa

    Three years after its launch, AFROSCREEN meets all its objectives, developing effective genomic surveillance to tackle epidemics  in sub-Saharan Africa The AFROSCREEN project, financed to the tune of €10 million by Agence Française de Développement (AFD), has been working since 2021 to set up or strengthen sequencing platforms and build an operational network for monitoring emerging...

  3. News | 2024.11.04

    A novel method for producing DNA-based therapies

    Scientists have combined enzyme and chemical techniques to develop an innovative method for producing synthetic DNA molecules. This novel approach opens up many new possibilities, especially for the production of large molecules that can be used for future therapies.

  4. Fiche maladie | 2015.10.06

    Aspergillosis

    Aspergillosis is a general term for infections caused by a type of mold (fungus) belonging to the genus Aspergillus. The mold that causes aspergillosis can be found everywhere in the environment in the form of spores, but in certain conditions it can become pathogenic, for example in immunocompromised people or those with chronic lung disease. The diseases caused by Aspergillus differ depending...

  5. Document de presse | 2025.02.28

    Bpifrance and the Institut Pasteur strengthen cooperation to support launch of startups based on research

    On February 27, 2025, Yasmine Belkaid, President of the Institut Pasteur, and Nicolas Dufourcq, CEO of Bpifrance, signed a cooperation agreement aimed at using their resources and skills to improve the transfer to industry of research results. This strategic partnership is designed to encourage the emergence of startups and innovative projects based on the Institut Pasteur’s research. It follows...

  6. News | 2023.05.23

    Creation of an European Biocluster for Emerging Infectious Diseases

    The project "Infectious Diseases Cluster" (IDCluster) has been selected for the Healthcare Innovation 2030 plan. This strategy aims to strengthen biomedical research in France. Coordinated by Lyonbiopôle and supported by the Auvergne-Rhône-Alpes region, this European-scale cluster aims to accelerate progress in the field of emerging diseases, by working with the Institut Pasteur among others.

  7. Article | 2019.05.21

    Antimicrobial resistance

    Antimicrobial resistance is dramatically increasing worldwide and is becoming one of the most urgent public health threats. There is an urgent need for actions to reverse the curve of antimicrobial resistance dissemination and to develop innovative drugs (antibiotics, antiparasitic, antifungals, antivirals, antivectors) and therapeutic strategies for safer and sustainable treatments of infectious...

  8. Document de presse | 2014.11.11

    Sanofi - Institut Pasteur Awards 2014

    Paris, France - November 13, 2014 - Sanofi and the Institut Pasteur awarded the Sanofi - Institut Pasteur awards for the third consecutive year. Four internationally renowned researchers were honored today for their work carried out in two major fields concerning world health: neglected tropical diseases and immunology.Press releaseNovember 13th, 2014 Created in 2012, these awards encourage...

  9. Document de presse | 2005.04.24

    Dengue: we are not all equal in the eyes of this disease

    Dengue, a virosis which is raging in tropical areas, is transmitted by mosquitoes. It affects 100 million people each year throughout the world. The genetic analysis of a large cohort of subjects who were hospitalised with this disease in Thailand has enabled researchers at the Institut Pasteur, together with researchers from Inserm (the National Institute for Health and Medical Research), to...

  10. Document de presse | 2004.10.10

    Inauguration of the Institut Pasteur of Shanghai - Chinese Academy of Sciences

    The Institut Pasteur of Shanghai-Chinese Academy of Sciences is being inaugurated today in the presence of Mr. Jacques Chirac, President of the French Republic, Mr. Lu Yongxiang, President of the Chinese Academy of Sciences, Mr. Han Zheng, Mayor of Shanghai, Mr. Philippe Kourilsky, President of the Institut Pasteur, and the Year of France in China's Committee of Honour.     Press...

Pages

Back to top